Delivery of messenger RNA using poly(ethylene imine)-poly(ethylene glycol)-copolymer blends for polyplex formation: Biophysical characterization and in vitro transfection properties

被引:53
作者
Debus, Heiko [1 ]
Baumhof, Patrick [2 ]
Probst, Jochen [2 ]
Kissel, Thomas [1 ]
机构
[1] Univ Marburg, Dept Pharmaceut & Biopharm, D-35032 Marburg, Germany
[2] CureVac GmbH, D-72076 Tubingen, Germany
关键词
mRNA; Poly(ethylene imine); Polyplex; Transfection; Gene delivery; GENE-TRANSFER; PLASMID DNA; EFFICIENT; COMPLEXES; PROSPECTS; CELLS; POLYETHYLENIMINE; EXPRESSION; RELEASE; PEPTIDE;
D O I
10.1016/j.jconrel.2010.09.007
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Nucleic acid based therapies have so far mainly been focused on plasmid DNA (pDNA), small interfering RNA (siRNA), antisense and immunostimulatory oligonucleotides. Messenger RNA (mRNA) was the subject of only a few studies. The objective of this investigation was the preparation of new composite polyplexes with mRNA consisting of poly(ethylene imine) (PEI) and poly(ethylene imine)-poly(ethylene glycol)-copolymers (PEI-PEG) as blends. These complexes were designed to increase the stability of mRNA, to improve transfection efficiency and to reduce cytotoxicity. Hydrodynamic diameters of the polyplexes were measured by dynamic light scattering, polyplex stability was analyzed by gel retardation assay and transfection efficiency of luciferase (Luc) encoding mRNA was evaluated under in vitro conditions. Most of the polyplexes generated showed small particle sizes <200 nm and positive zeta-potentials of +20 mV to +30 mV. Stable complexes were formed even at low nitrogen to phosphate ratios. Polyplexes with mRNA Luc and blends of low molecular weight PEI(5 kDa) and PEI(25 kDa)-PEG(20 kDa)(1)-block-copolymer showed protein expression as high as polyplexes with PEI(25 kDa). Moreover, luciferase expression was significantly higher than that obtained with one of the components alone. These results suggest that delivery systems for pulmonary application of mRNA merit further investigation under in vitro and in vivo conditions. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:334 / 343
页数:10
相关论文
共 38 条
[1]   Applications of RNA interference: current state and prospects for siRNA-based strategies in vivo [J].
Aigner, Achim .
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2007, 76 (01) :9-21
[2]   Liposome-mediated RNA transfection should be used with caution [J].
Barreau, Carine ;
Dutertre, Stephanie ;
Paillard, Luc ;
Osborne, H. Beverley .
RNA, 2006, 12 (10) :1790-1793
[3]  
Behr JP, 1997, CHIMIA, V51, P34
[4]   GENE-TRANSFER WITH SYNTHETIC CATIONIC AMPHIPHILES - PROSPECTS FOR GENE-THERAPY [J].
BEHR, JP .
BIOCONJUGATE CHEMISTRY, 1994, 5 (05) :382-389
[5]   Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cells [J].
Bettinger, T ;
Carlisle, RC ;
Read, ML ;
Ogris, M ;
Seymour, LW .
NUCLEIC ACIDS RESEARCH, 2001, 29 (18) :3882-3891
[6]   Light-Induced Gene Expression Using Messenger RNA Molecules [J].
Boe, Sigurd ;
Saeboe-Larssen, Stein ;
Hovig, Eivind .
OLIGONUCLEOTIDES, 2010, 20 (01) :1-6
[7]   A VERSATILE VECTOR FOR GENE AND OLIGONUCLEOTIDE TRANSFER INTO CELLS IN CULTURE AND IN-VIVO - POLYETHYLENIMINE [J].
BOUSSIF, O ;
LEZOUALCH, F ;
ZANTA, MA ;
MERGNY, MD ;
SCHERMAN, D ;
DEMENEIX, B ;
BEHR, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) :7297-7301
[8]  
Carralot Jean-Philippe, 2005, Genet Vaccines Ther, V3, P6, DOI 10.1186/1479-0556-3-6
[9]  
DWARKI VJ, 1993, METHOD ENZYMOL, V217, P644
[10]   Electrotransfer as a non viral method of gene delivery [J].
Favard, Cyril ;
Dean, David S. ;
Rols, Marie-Pierre .
CURRENT GENE THERAPY, 2007, 7 (01) :67-77